{"disease":{"id":"stargardt-disease","name":"stargardt disease"},"drugs":{"marketed":[{"drug_id":"echothiophate","indication_name":"Stargardt's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phospholine Iodide","generic_name":"ECHOTHIOPHATE","company_name":"Fera Pharms Llc","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":35,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02617966","title":"Rod and Cone Mediated Function in Retinal Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT07265895","title":"Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT03772665","title":"Safety and Efficacy of Emixustat in Stargardt Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":194,"lead_sponsor_name":"Kubota Vision Inc.","has_results":true},{"nct_id":"NCT06375239","title":"Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ray Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05244304","title":"Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Belite Bio, Inc","has_results":false},{"nct_id":"NCT07425574","title":"A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT06591806","title":"An Observational Study in Children and Adults With Stargardt Disease","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"AAVantgarde Bio Srl","has_results":false},{"nct_id":"NCT02875704","title":"Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy","phase":"","overall_status":"TERMINATED","enrollment_count":77,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT07417566","title":"A Study of DC6001 Tablet in Healthy Chinese Adult Subjects","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Heronova Pharmaceuticals","has_results":false},{"nct_id":"NCT04909398","title":"Pupil Dynamics and Color Vision for the Detection of Eye Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT06942572","title":"A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"Splice Bio","has_results":false},{"nct_id":"NCT04545736","title":"Oral Metformin for Treatment of ABCA4 Retinopathy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05956626","title":"A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Ocugen","has_results":false},{"nct_id":"NCT05258032","title":"Structural and Functional Characterization of Rare Ocular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Barcelona Macula Foundation","has_results":false},{"nct_id":"NCT06445322","title":"Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Ascidian Therapeutics, Inc","has_results":false},{"nct_id":"NCT06377150","title":"ABCA4-associated Disease in Childhood and Adolescence - a Phenotype Study","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT03297515","title":"Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Ophthalmos Research and Education Institute","has_results":false},{"nct_id":"NCT06805474","title":"A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Nanoscope Therapeutics Inc.","has_results":false},{"nct_id":"NCT03772938","title":"Stem Cells Therapy in Degenerative Diseases of the Retina","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT05904444","title":"The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Aier Eye Hospital, Guangzhou","has_results":false},{"nct_id":"NCT01736592","title":"Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":27,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT01367444","title":"Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05674058","title":"Function and Imaging Assessments for G1961E-associated Stargardt Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT04281732","title":"Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT07439887","title":"Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Ray Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06319872","title":"The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT06467344","title":"Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Ascidian Therapeutics, Inc","has_results":false},{"nct_id":"NCT05266014","title":"This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"RBP4 Pty Ltd","has_results":false},{"nct_id":"NCT00420602","title":"DHA Supplementation in Patients With STGD3","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT04489511","title":"Study of STG-001 in Subjects With Stargardt Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Stargazer Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06300476","title":"Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT07063251","title":"An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"HuidaGene Therapeutics Co., Ltd.","has_results":false},{"nct_id":"NCT05417126","title":"Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Nanoscope Therapeutics Inc.","has_results":false},{"nct_id":"NCT07266584","title":"Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration","phase":"NA","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Science Corporation","has_results":false}],"total":34},"guidelines":[],"source":"Drug Landscape verified database"}